Latvia vs Oman: Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and
Latvia
13.3%
in 2021
Oman
13.3%
in 2021
Latvia rank
112th
Oman rank
112th
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and over time
- Latvia
- Oman
How they compare
Latvia currently reports 13.3% against 13.3% in Oman, a difference of 0.0%.
Across all 22 years both countries report, Oman has been ahead every year.
Latvia ranks 112th and Oman ranks 112th of 185 countries.
Oman has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Latvia | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 17.8% | 22.6% | 4.8% | Oman |
| 2010s | 14.5% | 17.8% | 3.3% | Oman |
| 2020s | 13.1% | 13.3% | 0.2% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher mortality from cvd, cancer, diabetes or crd between exact ages 30 and, Latvia or Oman?
- Latvia, at 13.3% against 13.3% in Oman as of 2021.
- What is the difference in mortality from cvd, cancer, diabetes or crd between exact ages 30 and between Latvia and Oman?
- 0.0%, with Latvia ahead.
- How many years of comparable data are there for Latvia and Oman?
- 22 years are reported by both, from 2000 to 2021.
- How do Latvia and Oman rank globally for mortality from cvd, cancer, diabetes or crd between exact ages 30 and?
- Latvia ranks 112th and Oman ranks 112th of 185 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO), published as Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).